novidades científicas Novo

16:13 European Cardiovascular Disease Statistics 2017
10:47 CETP inhibitor meets primary endpoint in CV outcome study
9:54 Arrhythmias and devices
14:31 Clinically significant bleeding with low-dose rivaroxaban versus aspirin, in addition to P2Y12 inhibition, in acute coronary syndromes (GEMINI-ACS-1): a double-blind, multicentre, randomised trial
14:18 Rivaroxaban or Aspirin for Extended Treatment of Venous Thromboembolism

Which patients do we have now for RDN after HTN3

14 Outubro 2014

José A. Garcia Donaire

RESUMO DA APRESENTAÇÃO

APRESENTAÇÃO

Parte 1

Parte 2

Parte 3

Parte 4

Faça aqui o download da apresentação completa

Cardiac rehabilitation, key messages in 2014

14 Outubro 2014
0

Acute Coronary Syndromes. What is coming soon?

14 Outubro 2014
0

-->